Stocks On the Move: Celldex Therapeutics, Inc., Coupons.com Inc, and Nu Skin Enterprises, Inc.

CLDX, COUP, and NUS are moving sharply in Wednesday's trading

Nov 5, 2014 at 11:09 AM
facebook twitter linkedin


Around midday, three of the top market movers are biopharmaceutical name Celldex Therapeutics, Inc. (NASDAQ:CLDX), digital promotion platform Coupons.com Inc (NYSE:COUP), and anti-aging products marketer Nu Skin Enterprises, Inc. (NYSE:NUS). Here's a quick roundup of how CLDX, COUP, and NUS are performing on the charts so far.

  • CLDX has tumbled 11.5% this morning, despite a slimmer-than-expected third-quarter loss and revenue beat. At last check, the shares are perched at $14.67, bringing their year-to-date loss beyond 39%. In options land, traders have been buying to open puts over calls at a near-extreme rate in recent weeks. Specifically, during the past 10 days, Celldex Therapeutics, Inc. has racked up a put/call volume ratio of 1.24 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Not only does this number reveal that long puts outstrip long calls, it also ranks just 1 percentage point from a 12-month high.

  • COUP has tacked on 24.5% to trade at $15.49, after exceeding the Street's expectations in the earnings confessional. In fact, since hitting a record low of $11.61 in late August, the Wall Street rookie has rallied more than 33%. Nevertheless, just one brokerage firm is currently following Coupons.com Inc., and 7.4% of the equity's float is sold short, representing more than six sessions' worth of pent-up buying demand, at average daily trading levels. Should the shares maintain their recent positive momentum, a round of bullish initiations and/or a short-covering rally could be in the cards.

  • Finally, NUS plunged to an annual low of $39.46 earlier, and was last seen 15% south of breakeven at $42.84. Impacting the security today was a reduced current-quarter forecast, which overshadowed a third-quarter earnings and revenue beat. Year-to-date, Nu Skin Enterprises, Inc. is now sitting on a brow-raising deficit of 69%. Elsewhere, at the ISE, CBOE, and PHLX, the stock's 10-day put/call volume ratio of 1.00 ranks higher than 70% of all other readings from the past year -- suggesting options traders have been buying to open puts over calls at a faster-than-usual clip lately.
 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

SCHAEFFER'S JULY STOCKS REPORT AD
 


 


 
Special Offers from Schaeffer's Trading Partners